Skip to main content
Clinical Trials/NCT04982198
NCT04982198CompletedNot Applicable

Robotic-assisted Versus Conventional Total Knee Arthroplasty: A Multicenter and Randomized Controlled Clinical Trial

Zimmer Biomet1 site in 1 country99 target enrollmentStarted: July 7, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
99
Locations
1
Primary Endpoint
Mechanical axis alignment

Study Overview

Brief Summary

This is a multicenter, prospective and randomized controlled pre-market clinical Trial. Study subjects will be randomized into one of two operative groups: 1) TKA assisted with ROSA® Knee System; 2) TKA with conventional surgical instrumentation.

Detailed Description

The objective of this clinical trial is to measure the effectiveness and safety of the ROSA® Knee System in assisting surgeons with bone resections and implant positioning optimization through early clinical and radiographic outcomes compared with conventional surgical instrumentation in total knee arthroplasty (TKA).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient is age between 18 and 85 years old, inclusive;
  • Patient qualifies for a primary TKA based on the investigator's clinical judgement;
  • Patient is a candidate for commercially available Persona® Knee Joint Prosthese which is compatible with the ROSA® Knee System;
  • Patient is willing and able to provide written Informed Consent.

Exclusion Criteria

  • Patient planning to receive bilateral TKA surgery within 3 months;
  • Patient who has undergone revision surgery for partial or total knee arthroplasty of the ipsilateral knee;
  • Bone tumor patient who has undergone bilateral TKA;
  • Stable, painless ipsilateral knee arthrodesis within a satisfactory function and position;
  • Patient who has received partial or total knee arthroplasty for the contralateral knee within 6 months prior to scheduled primary TKA;
  • Patient has active, local infection or previous intra-articular infection in the affected joint;
  • Insufficient bone stock on femoral or tibial surfaces;
  • Skeletal immaturity;
  • Osteomalacia or any metabolic disorder which may impair bone formation;
  • Patient has neurologic disorders (e.g. Stroke);
  • Patient hs diseases that could lead to prosthesis instability, failure of prosthesis fixation or postoperative complications (e.g. Arthrodesis, Scoliosis, Lumbar Stenosis)
  • Patient has a hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum);
  • Patient has hip pathology severely limiting range of motion (e.g. arthrodesis, severe contractures, chronic severe dislocation);
  • Patients with severe knee instability caused by incomplete collateral ligaments, cruciate ligaments, and posterolateral structural injury;
  • Rheumatoid arthritis accompanied by an ulcer of the skin or history of recurrent breakdown of the skin;
  • Patient has severe angular knee deformity of >20° varus or >20° valgus;
  • Patient has a known or suspected sensitivity or allergy to one or more of the implant materials;
  • Patient has other contraindications specified by the implant manufacturer;
  • Patient is pregnant or considered a member of a protected population (e.g. prisoner, mentally incompetent);
  • In the past 1 month participated in or is participating in clinical trials related to other drugs and medical devices;
  • Any other conditions that the investigator considers inappropriate for participation in this trial.

Arms & Interventions

TKA with conventional surgical instrumentation

Active Comparator

TKA with conventional surgical instrumentation

Intervention: ROSA assisted TKA (Procedure)

TKA assisted with ROSA® Knee System

Experimental

TKA assisted with ROSA® Knee System

Intervention: ROSA assisted TKA (Procedure)

Outcomes

Primary Outcomes

Mechanical axis alignment

Time Frame: 6 weeks (±2 week) postoperatively

Deviation from neutral mechanical axis alignment based on full-leg weight-bearing X-ray at 6 weeks (±2 week) postoperatively.

Secondary Outcomes

  • Coronal Lower Limb Alignment(6 weeks (±2 week) postoperatively)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials